Migdal Insur. AI Stock Analysis
Want to see IL:MGDL full AI Analyst Report?
Migdal Insur. (MGDL) AI Stock Analysis
Migdal Insur.
(TASE:MGDL)
The overall score of 58 reflects a company with strong profitability and a fortress balance sheet, but these are significantly counterbalanced by weak cash generation and bearish market momentum. The primary strength is the dramatic margin improvement and high ROE, while the most significant risk is the negative free cash flow trend, which questions the quality of earnings. The stock's position below all major moving averages further pressures the score, and the lack of a dividend yield limits valuation appeal.
Migdal Insur. (MGDL) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 18.49B
- Dividend Yield
- ―
- Average Volume (3M)
- 2.26M
- Price to Earnings (P/E)
- 10.0
- Beta (1Y)
- 1.53
- Revenue Growth
- -9.35%
- EPS Growth
- 35.96%
- Country
- Israel
- Employees
- 4,435
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Life
Migdal Insur. Business Overview & Revenue Model
Company Description
Migdal Insurance and Financial Holdings Ltd., along with its various subsidiaries, offers a comprehensive suite of insurance, pension, and financial solutions to both individual and institutional clients across Israel. The firm's extensive offerings...
How the Company Makes Money
Migdal primarily makes money through a combination of underwriting-related income, fees for managing long-term savings assets, and investment income on assets it manages and holds. (1) Insurance underwriting and premiums: In its life, health, and gen...
Migdal Insur. Financial Statement Overview
Summary
Financial performance is mixed. Profitability is a clear strength, with TTM net margin improving to 5.3% and EBIT margin more than doubling to 8.9%, driving a strong ROE of 19.6%. The balance sheet is exceptionally strong with near-zero debt. However, these positives are offset by significant cash flow weakness, as TTM free cash flow turned deeply negative (-1.65B) and operating cash flow declined sharply, indicating current earnings are not converting to cash.
Income Statement
72PositiveBalance Sheet
85Very PositiveCash Flow
45Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.86B | 34.70B | 33.74B | 28.47B | 6.44B | 36.68B |
| Gross Profit | 34.04B | 34.70B | 32.38B | 28.47B | 6.44B | 36.68B |
| EBITDA | 3.60B | 3.40B | 1.47B | 1.28B | 1.51B | 2.49B |
| Net Income | 1.90B | 1.83B | 608.16M | 587.18M | 750.97M | 1.39B |
Balance Sheet | ||||||
| Total Assets | 256.34B | 246.30B | 219.64B | 204.86B | 196.90B | 204.16B |
| Cash, Cash Equivalents and Short-Term Investments | 2.35B | 3.52B | 46.09B | 41.00B | 38.79B | 37.79B |
| Total Debt | 8.34B | 8.24B | 8.18B | 5.97B | 7.19B | 5.42B |
| Total Liabilities | 245.48B | 236.34B | 210.09B | 196.26B | 188.80B | 195.59B |
| Stockholders Equity | 10.85B | 9.95B | 9.54B | 8.59B | 8.09B | 8.56B |
Cash Flow | ||||||
| Free Cash Flow | -1.65B | 5.52B | 3.05B | 2.15B | -3.11B | 6.88B |
| Operating Cash Flow | 2.71B | 5.60B | 3.38B | 2.44B | -2.85B | 7.12B |
| Investing Cash Flow | -473.00M | -405.00M | -353.88M | -284.03M | -254.66M | -245.25M |
| Financing Cash Flow | 569.00M | 645.00M | 630.00M | -1.35B | 1.18B | 773.24M |
Migdal Insur. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:MGDL, the sentiment is Negative. The current price of 1745.00 is below the 20-day moving average (MA) of 1789.10, below the 50-day MA of 1932.06, and below the 200-day MA of 1839.97, indicating a bearish trend. The MACD of -52.84 indicates Negative momentum. The RSI at 44.26 is Neutral, neither overbought nor oversold. The STOCH value of 59.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:MGDL.
Migdal Insur. Peers Comparison
Overall Rating
IL:IDIN80Outperform
IL:MMHD77Outperform
IL:PHOE76Outperform
IL:MGDL58Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | ILS 3.63B | 9.83 | ― | 7.94% | 3.98% | 14.95% | |
| 77Outperform | ILS 30.62B | 12.23 | ― | 3.43% | 18.14% | 49.80% | |
| 76Outperform | ILS 43.38B | 13.07 | ― | 3.32% | 10.88% | 24.40% | |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 58Neutral | ILS 19.06B | 9.99 | ― | ― | -9.35% | 35.96% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:MGDL | Migdal Insurance & Financial Holdings Ltd. | 1745.00 | 429.00 | 32.60% | |
| IL:PHOE | Phoenix Holdings Ltd. | 16660.00 | 3540.67 | 26.99% | |
| IL:MMHD | Menora Mivtachim Holdings Ltd. | 46660.00 | 10955.27 | 30.68% | |
| IL:ZUR | Zur Shamir Holdings Ltd. | 1049.00 | 76.05 | 7.82% | |
| IL:IDIN | I.D.I. Insurance Company Ltd. | 23860.00 | 4031.16 | 20.33% | |
| IL:IBIU | Poalim I.B.I.-Managing & Underwriting Ltd. | 663.00 | -226.21 | -25.44% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 20, 2026
